Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD

Clinical trial NCT00749411 · COMPLETED

Trial details

NCT number: NCT00749411
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2008-11-13
Primary completion: 2009-02-12
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.